Natural Grocers Wins GMO Labeling Appeal; Supplement Industry Under Pressure

This article first appeared in the February 2026 issue of Presence Marketing’s newsletter.

By Steven Hoffman

In January 2026, the regulatory framework governing the natural products industry encountered significant developments affecting how food and dietary supplements are labeled and regulated. Through a combination of judicial rulings, agency guidance, and legislative proposals, the requirements for transparency and product disclosure are shifting, presenting new compliance considerations for manufacturers and retailers alike.

For CPG brands, ingredient suppliers, and compliance officers, these updates signal a continued move toward explicit, on-package disclosure. Recent events indicate that both the courts and legislators are increasingly prioritizing clear, accessible information for consumers, challenging previous standards that allowed for digital or abbreviated disclosures.

This report outlines two primary developments from the start of the year: the U.S. Court of Appeals ruling in favor of Natural Grocers regarding Bioengineered (BE) disclosures, and a dual-front regulatory discussion involving the FDA and Senator Dick Durbin (D-IL) regarding the dietary supplement sector.

Federal Appeals Court Sides with Natural Grocers in GMO Ruling
In a decision delivered on Jan. 6, 2026, the U.S. Court of Appeals for the Ninth Circuit ruled in favor of a coalition of plaintiffs led by the Lakewood, CO-based retailer Natural Grocers by Vitamin Cottage (NYSE: NGVC) and the Center for Food Safety (CFS). The court’s decision effectively strikes down key portions of the USDA’s Bioengineered Food Disclosure Standard, addressing industry arguments that the previous rules contained exemptions that limited consumer access to information.

The "National Bioengineered Food Disclosure Standard" (NBFDS) has been a subject of debate since its inception. Critics, including the plaintiffs, argued that the USDA’s implementation allowed manufacturers to obscure the presence of genetically modified organisms (GMOs) through the use of digital links and unfamiliar terminology.

According to a Natural Grocers press release, the court’s ruling necessitates a significant revision of USDA rules. The outcome aligns with a long-standing position of Natural Grocers, the nation’s largest family-operated organic and natural grocery retailer, which has prohibited most GMO ingredients in its stores since 2012 and advocated for clearer labeling standards.

The court’s decision focused on three specific areas where the USDA’s previous rules were found to be insufficient or unlawful. Food and beverage manufacturers must now prepare for a regulatory environment that will likely require strategic adjustments in the next rulemaking cycle.

The "Bioengineered" Terminology Battle
First among the court's findings was the rejection of the USDA’s mandate that strictly required the use of the term "bioengineered." Plaintiffs successfully argued that this term is unfamiliar to the average shopper and infringed on free speech rights by prohibiting the use of terms consumers actually understand.

Under the overturned rules, a manufacturer was forced to use "bioengineered" even if their customer base was far more familiar with "GMO" or "Genetically Engineered." According to the Non-GMO Project, recent market research indicates that while 63% of consumers recognize the term "GMO," only 36% are familiar with "bioengineering." By mandating the lesser-known term, the USDA was seen as complicating disclosure. The ruling now paves the way for retailers and brands to use terms that resonate more clearly with their customers, potentially returning the familiar "GMO" acronym to federal disclosures.

Closing the Digital Divide: The End of QR Code Exclusivity
Operationally, a significant aspect of the ruling is the rejection of standalone QR codes as a sufficient means of disclosure. The USDA had previously allowed companies to forgo on-package text disclosures entirely in favor of a scannable code. Natural Grocers and the Center for Food Safety argued that this practice excluded consumers without smartphones, reliable internet access, or technical literacy—demographics that often include the elderly and rural populations.

The court agreed, ruling that companies cannot rely solely on digital disclosures. This decision impacts the "scan to learn more" approach that some large CPG companies had adopted. Brands that utilized digital links to manage label space must now redesign packaging to include clear, on-pack text or symbols accessible to the naked eye.

Highly Processed Ingredients: No More Hiding
Finally, the court found the USDA was incorrect in exempting highly processed foods—such as sugar from sugar beets or oil from canola—simply because the genetic material might not be detectable in the final refined product.

This "highly refined" exemption had been a major point of contention. Natural Grocers argued that even if the DNA is denatured or removed during processing, the ingredient still originates from a bioengineered crop system. The environmental and agricultural impacts remain, regardless of the final chemical structure of the sugar or oil.

"The court’s rejection of the ‘highly refined’ exemption reinforces an important principle: how food is made matters," noted Charlene Guzman, Communications Director of the Non-GMO Project, in a statement to Nosh. Brands that have relied on this exemption should expect closer scrutiny as the USDA revises its rules, particularly for ubiquitous ingredients like oils, sugars, and starches derived from GMO crops.

Heather Isely, Executive Vice President of Natural Grocers, stated that the decision reflects congressional intent. "Congress never intended to require the use of specific terms, the sole use of QR codes, or the exclusion of ingredients made from highly processed GMO crops," she said. "We are pleased the court recognized the shortcomings of the final rule and mandated corrections. Natural Grocers will remain actively engaged in the GMO regulatory process."

George Kimbrell, Legal Director of the Center for Food Safety, added that the ruling ensures consumers will eventually see "clear and accurate GMO label information."

The legal victory is consistent with Natural Grocers' long history of rigorous product standards. Founded in 1955 and with 168 stores across 21 states, the company has utilized a dynamic list—"Things We Won't Carry and Why"—to screen products. As stated in WholeFoods Magazine, if a company cannot verify non-GMO status, Natural Grocers will not stock the item.

The Supplement Industry’s Regulatory Tug-of-War
While the food industry assesses the implications of the GMO ruling, the dietary supplement sector is navigating a complex regulatory landscape. On one hand, the FDA is signaling potential flexibility regarding labeling requirements. On the other, Senator Dick Durbin has reintroduced legislation that could impose new registration requirements.

In a letter to the industry issued on Dec. 11, 2025, the FDA announced it is considering amendments to 21 C.F.R. § 101.93(d). This regulation currently governs the placement of the disclaimer required for structure/function claims under the Dietary Supplement Health and Education Act of 1994 (DSHEA).

Under current rules, supplements making claims such as "Supports heart health" must carry the standard disclaimer: "This statement has not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease." Regulations have historically required this disclaimer to appear on every single panel where a claim is made. For small bottles, this often leads to "label clutter," where the same disclaimer is repeated multiple times.

According to the National Law Review, the FDA is looking to remove the "each panel" requirement. Kyle Diamantas, FDA Deputy Commissioner for Human Foods, noted in the letter that revising this regulation would "reduce label clutter and unnecessary costs," aligning with the agency's historical enforcement posture.

Effective immediately, the FDA is exercising "enforcement discretion." The agency will not prioritize penalizing companies that do not repeat the disclaimer on every panel, provided the disclaimer appears at least once and is properly linked to the claims. However, companies should proceed with caution; this is a relaxation of placement frequency, not a removal of the disclaimer itself.

Not all experts view this relaxation as positive. Pieter Cohen, M.D., Associate Professor of Medicine at Harvard Medical School expressed concern to Nutraceutical Business Review, warning that reducing disclaimer visibility could mislead consumers. "Then you start saying things such as, ‘We only need it on the actual bottle.’ Then you let the print get smaller," Cohen noted, highlighting the tension between industry simplification and consumer protection.

Durbin Reintroduces the Dietary Supplement Listing Act
While the FDA offers potential labeling flexibility, Congress is considering increased oversight. On Jan. 17, 2026, Senator Dick Durbin reintroduced the Dietary Supplement Listing Act, aimed at modernizing FDA oversight through Mandatory Product Listing (MPL).

The core of the bill would require manufacturers to register products with the FDA, providing product names, ingredient lists, electronic copies of labels, allergen statements, and structure/function claims. This data would populate a public database accessible to consumers.

Senator Durbin’s argument is rooted in the growth of the sector. When DSHEA passed in 1994, there were approximately 4,000 supplements on the market. Today, the FDA estimates there are over 100,000. Durbin argues that the FDA cannot effectively regulate a market it cannot track. "FDA—and consumers—should know what dietary supplements are on the market and what ingredients are included in them. This is FDA’s most basic function," Durbin stated.

As reported by RiverBender, the bill has garnered endorsements from the American Medical Association, US Pharmacopeia, and Consumer Reports. However, the industry itself remains divided, illustrating a strategic difference between its two major trade associations.

A House Divided: CRN vs. NPA
The reintroduction of the Listing Act has reignited a debate between the Council for Responsible Nutrition (CRN) and the Natural Products Association (NPA).

The CRN supports the legislation, viewing transparency as a path to legitimacy and consumer trust. Steve Mister, President and CEO of CRN, stated, "In an era when the Administration has rightly called for more transparency about what we eat and how food is made, it makes sense to apply that same transparency to dietary supplements." The CRN views the registry as a tool to distinguish legitimate, responsible brands from "fly-by-night" actors selling tainted products, arguing that a federal registry is "a transparency tool—not a barrier to innovation."

Conversely, the NPA opposes the bill. Daniel Fabricant, Ph.D., President and CEO of NPA, characterizes it as unnecessary bureaucracy that burdens lawful companies while failing to stop bad actors. Fabricant argues that DSHEA already gives the FDA ample authority; the agency simply fails to use it.

As detailed in Nutrition Insight, NPA fears that the FDA could use the list to arbitrarily challenge ingredients, citing the recent (and reversed) attempt to ban NMN (nicotinamide mononucleotide) as an example of regulatory overreach. "This proposal will hand bureaucrats new leverage over lawful products, cool innovation, and punish companies investing in new science," Fabricant warned.

Conclusion: The Transparency Mandate
As the year progresses, the common thread connecting the Natural Grocers victory and the Durbin bill is transparency. In the food aisle, the courts have ruled that accessibility is key—labels must be readable without a smartphone and use terms the public understands. In the supplement aisle, the debate continues over whether transparency requires a federal database of every product on the market.

For business leaders, the takeaway is operational agility. Packaging workflows must be adaptable, supply chain documentation must be robust, and regulatory monitoring must be constant. The "clean label" trend is extending beyond ingredients to include the regulatory integrity of the package itself.

Natural Grocers has signaled it will remain active, with executive Heather Isely stating, "Natural Grocers will remain actively engaged in the GMO regulatory process." Brands wishing to remain on the shelves of such high-standard retailers must ensure their transparency efforts meet these rising expectations.

Steven Hoffman is Managing Director of Compass Natural Marketing, a strategic communications and brand development agency serving the natural and organic products industry. Learn more at www.compassnatural.com.

NPA Criticizes Senate for Excluding Funding for CBD Health Safety Evaluation

Photo: Pixabay

Originally Appeared in Presence Marketing News, October 2019
By Steven Hoffman

The Natural Products Association (NPA), based in Washington, DC, reported that the U.S. Senate Agriculture Appropriations Committee failed to include legislation passed earlier this summer in the House of Representatives that would have appropriated $100,000 for the FDA to perform a health hazard evaluation on CBD. The health hazard evaluation would have determined and set a safe use level for the consumption of CBD. This process has precedent, allowing FDA to exercise enforcement discretion on natural products that contain levels of an approved drug ingredient, most notably red yeast rice, reported Nutritional Outlook. The Senate agriculture committee only included language that instructed FDA to report back to them in 90 days, but otherwise, no meaningful progress was made in regulating CBD products, NPA said. “What we saw today was the U.S. Senate Agriculture Committee fail to include any meaningful legislative language that would force the FDA to do its job when it comes to CBD. Sadly, this approach will lead to nothing but problems. We are seeing that play out with the vaping crisis and we are desperately hoping to avoid that with CBD,” said Daniel Fabricant, PhD, president and CEO of NPA, in a statement. “This should have been an easy choice for the committee, they should have taken their lead from the U.S. House of Representatives where Congressman (Jerry) McNerney had already had an amendment pass that would actually protect American consumers. However, the fight is not over. We are continuing our work to ensure that the one in seven Americans that use a CBD product everyday have the ability to believe that the FDA is doing its job, and not taking the path of least resistance. We encourage everyone to tell their Congressman and Senators to set a safe level of daily consumption for CBD,” Fabricant said.

Natural Products Association (NPA) Files for Bankruptcy

Photo: Natural Products Association (NPA)

Originally Appeared in Presence Marketing News, September 2019
By Steven Hoffman

The Natural Products Association, (NPA) the oldest trade group in the natural products industry, filed for bankruptcy protection on August 19, 2019, which it attributed to six straight years of losses and a costly arbitration with the association’s former CFO. According to Reuters, NPA CEO Daniel Fabricant said in a filing with the U.S. bankruptcy court in Wilmington, DE, that the Chapter 11 case will provide a “breathing spell” for the Washington, D.C.-based trade group to focus on advocacy and membership. Founded in 1936 and formerly known as the National Nutritional Foods Association, NPA said it has more than 1,000 members comprising over 10,000 retail, manufacturing, wholesale and distribution locations for natural foods, dietary supplements and natural health and beauty products. According to Reuters, NPA’s former CFO Brent Weickert holds the largest unsecured claim in the bankruptcy petition – a disputed $780,179 arbitration settlement awarded as a result of a wrongful termination lawsuit filed by Weickert in 2015 against NPA.